Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-24-019023
Filing Date
2024-11-13
Accepted
2024-11-13 16:35:48
Documents
97
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm   iXBRL 10-Q 1795003
2 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 6772
3 EXHIBIT 31.2 exhibit31-2.htm EX-31.2 6786
4 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 2400
5 EXHIBIT 32.2 exhibit32-2.htm EX-32.2 2403
  Complete submission text file 0001062993-24-019023.txt   9757085

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flgc-20240930.xsd EX-101.SCH 115225
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flgc-20240930_cal.xml EX-101.CAL 66787
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flgc-20240930_def.xml EX-101.DEF 297356
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flgc-20240930_lab.xml EX-101.LAB 1284940
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flgc-20240930_pre.xml EX-101.PRE 473832
100 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 1460102
Mailing Address 3230 W. COMMERCIAL BOULEVARD SUITE 180 FORT LAUDERDALE FL 33309
Business Address 3230 W. COMMERCIAL BOULEVARD SUITE 180 FORT LAUDERDALE FL 33309 416-861-2267
Flora Growth Corp. (Filer) CIK: 0001790169 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40397 | Film No.: 241455023
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)